Physiologically active substance FA-5859, its derivative, their
production and use
    2.
    发明授权
    Physiologically active substance FA-5859, its derivative, their production and use 失效
    生理活性物质FA-5859,其衍生物,其生产和使用

    公开(公告)号:US4521432A

    公开(公告)日:1985-06-04

    申请号:US442368

    申请日:1982-11-17

    摘要: Physiologically active substance FA-5859 and its deacetyl compound represented by the formula: ##STR1## wherein R.sub.1 is a hydrogen atom or an acetyl group, are produced by a cultivation of a microorganism of the genus Emericella or Aspergillus (compound wherein R.sub.1 is an acetyl group) or by a method of chemical synthesis (compound wherein R.sub.1 is a hydrogen atom or an acetyl group).Said compounds or a salt thereof have excellent fatty acid degradation inhibiting activity and is useful as an antidiabetic agent in mammalian animals or as a biochemical reagent for studies on fatty acid metabolism.

    摘要翻译: 生理活性物质FA-5859及其由下式表示的脱乙酰基化合物:其中R1是氢原子或乙酰基,是通过培养艾美菌属或曲霉属的微生物(其中R1是乙酰基的化合物 基团)或化学合成方法(其中R 1为氢原子或乙酰基的化合物)。 所述化合物或其盐具有优异的脂肪酸降解抑制活性,并且可用作哺乳动物中的抗糖尿病剂或用作脂肪酸代谢研究的生物化学试剂。

    Carbapenem compounds and their production
    3.
    发明授权
    Carbapenem compounds and their production 失效
    碳青霉烯化合物及其生产

    公开(公告)号:US4409147A

    公开(公告)日:1983-10-11

    申请号:US236310

    申请日:1981-02-20

    CPC分类号: C07D477/20 C12P17/184

    摘要: Novel carbapenem compounds, which are shown by the formula (I): ##STR1## wherein R is --SO.sub.3 H or hydrogen, or a physiologically acceptable salt thereof, are useful as a bactericide or disinfectant, and also produce a synergistic effect with penicillin and/or cephalosporin antibiotic agents.The compound of the formula (I) can be produced by subjecting to reduction reaction a compound of the formula: ##STR2## wherein R has the same meaning as defined above, or a salt thereof.

    摘要翻译: 由式(I)表示的新型碳青霉烯化合物:其中R为-SO 3 H或氢的化合物或其生理学上可接受的盐可用作杀菌剂或消毒剂,并且还可产生与 青霉素和/或头孢菌素抗生素。 式(I)化合物可以通过将下式化合物或其盐与下式化合物进行还原反应来制备:其中R具有与上述相同的含义。

    Isomerization of .beta.-lactam compounds
    5.
    发明授权
    Isomerization of .beta.-lactam compounds 失效
    β-内酰胺化合物异构化

    公开(公告)号:US4497742A

    公开(公告)日:1985-02-05

    申请号:US351927

    申请日:1982-02-24

    CPC分类号: C07D477/20 C12P17/184

    摘要: Compounds of the formula (I): ##STR1## wherein R is an ethyl group which may optionally be substituted and n is 0 or 1, or a physiologically acceptable salt thereof, can be produced by subjecting to isomerization a compound of the formula (II): ##STR2## wherein R and n have the same meaning as defined above, or a salt thereof, by using a quaternary ammonium halide and are useful as a bactericide or disinfectant, and also a synergistic effect with penicillin and/or cephalosporin antibiotic agents.Among the compounds of the formula (I), compounds shown by the formula: ##STR3## wherein R.sub.6 is H or --SO.sub.3 H, as well as salts thereof, are novel.

    摘要翻译: 式(I)化合物:其中R是可任意取代的乙基,n为0或1的化合物或其生理学上可接受的盐可以通过将 式(II):其中R和n具有与上述相同的含义,或其盐,通过使用季铵卤化物,并且可用作杀菌剂或消毒剂,以及与青霉素的协同效应 和/或头孢菌素抗生素。 在式(I)的化合物中,由下式表示的化合物:其中R6是H或-SO3H,以及其盐是新颖的。

    Antibiotics produced from the microorganism nocardice
    7.
    发明授权
    Antibiotics produced from the microorganism nocardice 失效
    从微生物诺卡氏菌产生的抗生素

    公开(公告)号:US4187292A

    公开(公告)日:1980-02-05

    申请号:US815050

    申请日:1977-07-12

    IPC分类号: C12P1/06

    摘要: The present invention relates to antibiotics C-14919 E-1 and E-2 produced by cultivating a microorganism of the genus Nocardia. These antibiotics display a wide activity against e.g. Gram-positive bacteria, fungi and yeast and are useful as germicides or disinfectants.

    摘要翻译: 本发明涉及通过培养诺卡氏菌属的微生物而产生的抗生素C-14919E-1和E-2。 这些抗生素显示出广泛的活性。 革兰氏阳性菌,真菌和酵母,可用作杀菌剂或消毒剂。

    Antibiotics produced from the microorganism nocardia
    9.
    发明授权
    Antibiotics produced from the microorganism nocardia 失效
    从微生物诺卡氏菌产生的抗生素

    公开(公告)号:US4245047A

    公开(公告)日:1981-01-13

    申请号:US66823

    申请日:1979-08-14

    IPC分类号: C12P1/06 C12P13/00 C12P17/10

    摘要: The present invention relates to a method of producing the antibiotics C-14919 E-1 and/or E-2 by cultivating an antibiotic C-14919 E-1 and/or E-2 producing strain of the genus Nocardia in a culture medium and accumulating said antibiotics. These antibiotics have a wide range of antibiotic activity and they are useful as germicides or disinfectants.

    摘要翻译: 本发明涉及通过在培养基中培养抗诺卡氏菌属的抗生素C-14919E-1和/或产生E-2的菌株来生产抗生素C-14919E-1和/或E-2的方法,以及 累积抗生素。 这些抗生素具有广泛的抗生素活性,可用作杀菌剂或消毒剂。

    Antibiotic G-6302
    10.
    发明授权
    Antibiotic G-6302 失效
    抗生素G-6302

    公开(公告)号:US4229436A

    公开(公告)日:1980-10-21

    申请号:US971089

    申请日:1978-12-15

    CPC分类号: C12P1/04

    摘要: A novel Antibiotic G-6302 is produced by cultivating a microorganism belonging to the genus Pseudomonas and being capable of producing Antibiotic G-6302 in a culture medium to have Antibiotic G-6302 elaborated and accumulated in the cultured broth and recovering the antibiotic.Antibiotic G-6302 is useful as a germicide or disinfectant.

    摘要翻译: 通过培养属于假单胞菌属的微生物并且能够在培养基中产生抗生素G-6302以使抗生素G-6302在培养的肉汤中精制并积累并回收抗生素来生产新型抗生素G-6302。 抗生素G-6302可用作杀菌剂或消毒剂。